瑞邦药业 (834672.oc)

+ 收藏

财务摘要(报告期)(瑞邦药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.180.140.180.14
 每股收益 - 稀释(元) -0.140.180.14
 每股收益 - 期末股本摊薄(元) 0.180.140.180.14
 每股净资产BPS(元) 2.172.132.142.10
 每股经营活动产生的现金流量净额(元) 0.03-0.080.210.05
 每股营业收入(元) 1.470.721.680.86
关键比率:
 净资产收益率 - 摊薄(%) 8.256.438.466.74
 净资产收益率 - 加权(%) -6.198.576.50
 净资产收益率 - 平均(%) 8.306.418.526.73
 净资产收益率 - 扣除(%) 7.756.078.696.87
 总资产净利率 - 平均(%) 5.704.216.094.89
 总资产报酬率ROA(%) 6.785.247.696.01
 投入资本回报率ROIC(%) 7.515.518.335.96
 销售毛利率(%) 49.2151.8445.4342.29
 销售净利率(%) 12.1418.8610.7716.42
 资产负债率(%) 31.8137.2830.9528.72
 资产周转率(倍) 0.470.220.570.30
 销售商品提供劳务收到的现金/营业收入(%) 125.87131.39115.1097.53
 营业利润同比增长率(%) -5.090.42-17.10-17.64
 营业收入同比增长率(%) -12.41-15.97-11.56-14.04
 利润总额同比增长率(%) -1.762.00-19.85-18.85
 归属母公司股东的净利润同比增长率(%) -1.21-3.51-13.73-18.54
 扣非后归属母公司股东的净利润同比增长率(%) -9.57-10.56-5.11-14.08
 总资产同比增长率(%) 2.6315.058.80-6.09
 总负债同比增长率(%) 5.4849.3429.70-20.55
 净资产同比增长率(%) 1.351.241.471.33
利润表摘要:
 营业总收入(元) 132,592,539.1965,218,730.78151,386,352.7877,613,301.85
 营业总成本(元) 115,399,688.1651,251,582.01132,754,126.2762,823,849.49
 营业收入(元) 132,592,539.1965,218,730.78151,386,352.7877,613,301.85
 营业利润(元) 17,583,499.0714,723,160.4718,525,553.0914,661,452.97
 利润总额(元) 17,581,748.3614,734,777.7017,896,496.0914,446,102.75
 净利润(元) 16,100,834.6912,299,548.1316,297,250.6812,747,161.50
 归属母公司股东的净利润(元) 16,100,834.6912,299,548.1316,297,250.6812,747,161.50
 非经常性损益(元) 971,616.65678,374.13-432,916.62-246,730.43
 归属母公司股东的净利润扣除非经常性损益(元) 15,129,218.0411,621,174.0016,730,167.3012,993,891.93
资产负债表摘要:
 流动资产(元) 101,286,947.44121,101,157.4499,745,019.7089,347,860.34
 固定资产(元) 141,871,562.56138,738,841.12137,724,250.82141,436,256.62
 资产总计(元) 286,258,664.51305,157,230.04278,924,964.99265,228,743.56
 流动负债(元) 90,379,412.56113,371,137.8885,921,444.9475,662,052.76
 非流动负债(元) 668,319.83376,446.60393,422.62506,682.55
 负债合计(元) 91,047,732.39113,747,584.4886,314,867.5676,168,735.31
 股东权益(元) 195,210,932.12191,409,645.56192,610,097.43189,060,008.25
 归属母公司股东的权益(元) 195,210,932.12191,409,645.56192,610,097.43189,060,008.25
 资本公积(元) 7,620,664.747,620,664.747,620,664.747,620,664.74
 盈余公积(元) 17,832,097.9617,159,558.4615,887,289.9115,332,574.23
 未分配利润(元) 79,758,169.4276,629,422.3679,102,142.7876,106,769.28
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 166,898,159.2585,689,489.33174,248,683.6675,698,664.50
 经营活动产生的现金净流量(元) 2,514,382.41-7,152,881.2418,562,538.454,292,974.86
 购建固定无形长期资产支付的现金(元) 12,014,140.2510,515,564.4112,831,414.127,210,160.51
 投资支付的现金(元) 14,257,666.4410,000,000.0073,585,740.0043,000,000.00
 投资活动产生的现金净流量(元) -10,734,463.89-9,392,522.50-19,572,767.13-12,313,898.42
 取得借款收到的现金(元) 100,382,921.0064,000,000.0081,000,000.0037,000,000.00
 筹资活动产生的现金净流量(元) 10,999,894.2235,594,195.81-8,244,846.15-711,919.76
 现金及现金等价物净增加(元) 2,883,622.0219,329,951.60-8,674,115.31-8,677,282.13
 期末现金及现金等价物余额(元) 9,499,408.6525,945,738.236,615,786.636,612,619.81
 折旧与摊销(元) 11,533,970.505,473,681.2110,750,265.035,352,806.19
公告日期 2024-04-292023-08-292023-04-272022-08-30
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院